Inactive Instrument

Analyst Reco. Churchill Capital Corp Nyse

Equities

CCC.U

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Goldman Sachs Adjusts Price Target on Clarivate to $7.50 From $8.50, Maintains Buy Rating	05-09	MT
Barclays Trims Price Target on Clarivate to $6 From $7, Maintains Underweight Rating	02-28	MT
Oppenheimer Trims Clarivate Price Target to $10 From $11, Maintains Outperform Rating	02-28	MT
RBC Cuts Price Target on Clarivate to $8 From $10, Cites Limited Visibility on Second-Half Turnaround; Sector Perform Kept	02-28	MT
RBC Raises Price Target on Clarivate to $10 From $8, Expects Return to Growth in 2024, Keeps Sector Perform Rating	01-22	MT
Oppenheimer Ups Price Target on Clarivate to $11 From $10, Keeps Outperform Rating	01-08	MT
Wells Fargo Downgrades Clarivate to Underweight From Equalweight, Price Target is $8	12-15	MT
Oppenheimer Adjusts Clarivate Price Target to $10 From $11, Maintains Outperform Rating	05/10/23	MT
Citigroup Cuts Price Target on Clarivate to $8 From $10, Maintains Neutral Rating	26/09/23	MT
Barclays Downgrades Clarivate to Underweight From Equal Weight, Adjusts Price Target to $7 From $8	08/09/23	MT
RBC Downgrades Clarivate to Sector Perform From Outperform, Says Potential for Strategic Optionality has Declined, Cuts Price Target to $8 From $9	25/08/23	MT
BofA Securities Downgrades Clarivate to Underperform From Neutral, Adjusts Price Target to $6 From $10	07/08/23	MT
Wells Fargo Downgrades Clarivate to Equalweight From Overweight, Adjusts Price Target to $8 From $15	04/08/23	MT
Oppenheimer Adjusts Clarivate Price Target to $11 From $12, Maintains Outperform Rating	04/08/23	MT
RBC Cuts Price Target on Clarivate to $9 From $14, Maintains Outperform Rating	04/08/23	MT
Oppenheimer Adjusts Clarivate Price Target to $12 From $11, Maintains Outperform Rating	05/07/23	MT
Oppenheimer Initiates Coverage on Clarivate With Outperform Rating, $11 Price Target	13/06/23	MT
Goldman Sachs Cuts Clarivate's Price Target to $11 From $12.40, Buy Rating Maintained	10/05/23	MT
Morgan Stanley Adjusts Price Target on Clarivate to $11 From $12, Maintains Equal-Weight Rating	10/05/23	MT
Wells Fargo Adjusts Price Target on Clarivate to $15 From $14, Maintains Overweight Rating	02/03/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Churchill Capital Corp Nyse

Equities

CCC.U

Analyst Reco.

Filters